IRIS UniCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.249
NA - Nord America 3.221
AS - Asia 2.470
SA - Sud America 571
AF - Africa 86
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.088
SG - Singapore 1.176
DE - Germania 1.055
CN - Cina 697
SE - Svezia 510
BR - Brasile 462
IT - Italia 433
FR - Francia 234
PL - Polonia 218
GB - Regno Unito 183
FI - Finlandia 147
UA - Ucraina 123
IN - India 112
IE - Irlanda 108
VN - Vietnam 105
CA - Canada 81
ID - Indonesia 81
RU - Federazione Russa 64
JP - Giappone 44
AR - Argentina 42
MX - Messico 36
AT - Austria 29
KR - Corea 28
TR - Turchia 28
BD - Bangladesh 26
HK - Hong Kong 25
NL - Olanda 23
TW - Taiwan 22
CI - Costa d'Avorio 21
IQ - Iraq 21
CZ - Repubblica Ceca 20
ZA - Sudafrica 20
BE - Belgio 19
VE - Venezuela 14
EC - Ecuador 13
ES - Italia 13
IR - Iran 13
MA - Marocco 11
PK - Pakistan 11
CO - Colombia 10
IL - Israele 10
LT - Lituania 9
PY - Paraguay 9
UZ - Uzbekistan 9
CL - Cile 8
GR - Grecia 8
KE - Kenya 8
SA - Arabia Saudita 8
CH - Svizzera 7
JO - Giordania 7
UY - Uruguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
MY - Malesia 6
PT - Portogallo 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 5
HN - Honduras 5
NP - Nepal 5
PE - Perù 5
BG - Bulgaria 4
EE - Estonia 4
HU - Ungheria 4
KG - Kirghizistan 4
RO - Romania 4
RS - Serbia 4
AL - Albania 3
DK - Danimarca 3
ET - Etiopia 3
LV - Lettonia 3
NO - Norvegia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
CG - Congo 2
CY - Cipro 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 9.595
Salva come PNG Salva come JPEG
Città #
Singapore 616
Chandler 482
Ashburn 311
Warsaw 200
Munich 173
Beijing 150
Fairfield 116
New York 106
Dublin 105
Hefei 94
Rome 93
Jacksonville 91
Los Angeles 90
Houston 85
San Mateo 81
Helsinki 80
Jakarta 74
Wilmington 65
Nanjing 64
Dearborn 60
Ann Arbor 58
The Dalles 57
Dallas 55
Seattle 55
Woodbridge 54
Frankfurt am Main 51
Nürnberg 50
Boston 47
Marseille 46
Milan 46
Moscow 44
Bremen 37
Cattolica 37
Chicago 35
Lancaster 35
São Paulo 35
Princeton 34
Ho Chi Minh City 32
Buffalo 30
Nanchang 29
London 28
Seoul 27
Tokyo 26
Kent 25
Nuremberg 24
Redwood City 24
Hong Kong 23
Hyderabad 23
Hanoi 22
Montreal 22
Toronto 22
Abidjan 21
Cambridge 20
Lappeenranta 20
Lawrence 20
Phoenix 19
Rio de Janeiro 19
Santa Clara 19
Boardman 18
Guangzhou 18
Brno 17
Brooklyn 17
Brussels 17
Hangzhou 17
Mexico City 17
Tianjin 17
Turku 17
Atlanta 16
Leawood 16
Vienna 16
Belo Horizonte 15
Poplar 15
Denver 14
San Francisco 14
Stockholm 14
Johannesburg 13
Düsseldorf 12
Fremont 12
Orem 12
Amsterdam 11
Changsha 11
Izmir 11
Manchester 11
Shanghai 11
Wroclaw 11
Baghdad 10
Chennai 10
Kunming 10
Lauterbourg 10
Norwalk 10
Pune 10
Florence 9
Kyoto 9
Auburn Hills 8
Bexley 8
Dhaka 8
Haiphong 8
Hebei 8
New Delhi 8
Paris 8
Totale 4.931
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 403
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 321
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 315
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 262
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 243
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 215
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 209
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Correlation between paraproteinaemia and viral reactivation after allo-SCT 185
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 175
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 174
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 163
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 161
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 159
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 159
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 151
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 146
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 142
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 137
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 136
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 136
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 131
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 131
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 131
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 126
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 125
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 122
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 121
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 119
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 118
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 117
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 116
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 113
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 109
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 108
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 107
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 99
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 99
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 97
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 95
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 95
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 92
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 88
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 84
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 84
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 84
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 83
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 82
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 82
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 82
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 82
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 81
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 80
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 80
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 77
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 77
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 76
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 76
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 76
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 75
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 73
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 64
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 64
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 64
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 62
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 61
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 61
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 58
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 57
External validation of the accuracy of 'CLLflow score' 57
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 56
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 49
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 44
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 36
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 13
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 10
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 9
Totale 9.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 53 41 26 44 42 143 28
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024738 33 181 28 41 26 100 54 54 10 29 86 96
2024/20252.019 65 61 118 101 169 108 145 92 241 185 405 329
2025/20262.463 582 156 262 504 797 162 0 0 0 0 0 0
Totale 9.756